총 50 건의 최근 내부자 거래 내역가 기록되었습니다 POINT Biopharma Global Inc. (PNT), 포함 25 건 매수 및 21 건 매도. 내부자 매수 총액은 $14.9M 내부자 매도 총액은 $70.58M.
최근 활동이 있는 주요 내부자에는 Silber Allan C, Lubner David Charles, Malik Rajesh. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — PNT
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2023-12-27 |
Silber Allan C |
Executive Chairman |
주식 반환 |
537,322 |
$6.78 |
$3.64M |
- |
| 2023-12-27 |
Lubner David Charles |
Director |
주식 반환 |
44,749 |
$9.12 |
$408.11K |
- |
| 2023-12-27 |
Malik Rajesh |
Director |
주식 반환 |
44,749 |
$9.12 |
$408.11K |
- |
| 2023-12-27 |
Fleshner Neil E. |
Chief Medical Officer |
주식 반환 |
84,257 |
$6.78 |
$571.26K |
- |
| 2023-12-27 |
Demers William L. |
Chief Financial Officer |
주식 반환 |
131,355 |
$6.78 |
$890.59K |
- |
| 2023-12-27 |
Goodman Jonathan R. |
Director |
주식 반환 |
44,749 |
$9.12 |
$408.11K |
- |
| 2023-12-27 |
Margolin Yael |
Director |
주식 반환 |
44,749 |
$9.12 |
$408.11K |
- |
| 2023-12-27 |
Mccann Joe A. |
Chief Executive Officer |
주식 반환 |
692,643 |
$6.78 |
$4.7M |
- |
| 2023-12-27 |
Hogue Gerald L. |
Director |
주식 반환 |
44,749 |
$9.12 |
$408.11K |
- |
| 2023-12-27 |
Jensen Jessica D. |
EVP Clinical Development |
주식 반환 |
136,055 |
$6.78 |
$922.45K |
- |
| 2023-12-27 |
Kelly Justyna |
Chief Operating Officer |
주식 반환 |
98,358 |
$6.78 |
$666.87K |
- |
| 2023-12-26 |
Lubner David Charles |
Director |
공개매수 (매도) |
35,400 |
$12.50 |
$442.5K |
3,600 |
| 2023-12-26 |
Malik Rajesh |
Director |
공개매수 (매도) |
3,700 |
$12.50 |
$46.25K |
- |
| 2023-12-26 |
Goodman Jonathan R. |
Director |
공개매수 (매도) |
41,872 |
$12.50 |
$523.4K |
- |
| 2023-12-26 |
Hogue Gerald L. |
Director |
공개매수 (매도) |
21,596 |
$12.50 |
$269.95K |
- |
| 2023-12-22 |
Silber Allan C |
Executive Chairman |
공개매수 (매도) |
71,744 |
$12.50 |
$896.8K |
- |
| 2023-12-22 |
Fleshner Neil E. |
Chief Medical Officer |
공개매수 (매도) |
358 |
$12.50 |
$4.48K |
- |
| 2023-12-22 |
Mccann Joe A. |
Chief Executive Officer |
공개매수 (매도) |
3,494,153 |
$12.50 |
$43.68M |
- |
| 2023-12-18 |
Bvf Partners L P/il |
Officer |
정보 매도 |
896,366 |
$12.45 |
$11.16M |
- |
| 2023-11-06 |
Mccann Joe A. |
Chief Executive Officer |
증여 (지급) |
120,000 |
- |
- |
3,494,153 |
| 2023-11-03 |
Silber Allan C |
Executive Chairman |
증여 (지급) |
500,000 |
- |
- |
38,087 |
| 2023-11-02 |
Bvf Partners L P/il |
10 Percent Owner |
처분 |
- |
- |
- |
896,366 |
| 2023-10-31 |
Fleshner Neil E. |
Chief Medical Officer |
증여 (지급) |
250,000 |
- |
- |
2,773,045 |
| 2023-06-13 |
Martell Bridget A |
Director |
RSU 부여 |
80,503 |
$10.08 |
$811.47K |
80,503 |
| 2023-06-12 |
Martell Bridget A |
Director |
알 수 없음 |
- |
- |
- |
- |
| 2023-06-01 |
Lubner David Charles |
Director |
RSU 부여 |
44,749 |
$9.12 |
$408.11K |
44,749 |
| 2023-06-01 |
Malik Rajesh |
Director |
RSU 부여 |
44,749 |
$9.12 |
$408.11K |
44,749 |
| 2023-06-01 |
Goodman Jonathan R. |
Director |
RSU 부여 |
44,749 |
$9.12 |
$408.11K |
44,749 |
| 2023-06-01 |
Margolin Yael |
Director |
RSU 부여 |
44,749 |
$9.12 |
$408.11K |
44,749 |
| 2023-06-01 |
Hogue Gerald L. |
Director |
RSU 부여 |
44,749 |
$9.12 |
$408.11K |
44,749 |
| 2023-03-28 |
Silber Allan C |
10 Percent Owner, Officer: Executive Chairman |
RSU 부여 |
537,322 |
$6.78 |
$3.64M |
537,322 |
| 2023-03-28 |
Fleshner Neil E. |
Chief Medical Officer |
RSU 부여 |
84,257 |
$6.78 |
$571.26K |
84,257 |
| 2023-03-28 |
Demers William L. |
Chief Financial Officer |
RSU 부여 |
131,355 |
$6.78 |
$890.59K |
131,355 |
| 2023-03-28 |
Mccann Joe A. |
Chief Executive Officer |
RSU 부여 |
692,643 |
$6.78 |
$4.7M |
692,643 |
| 2023-03-28 |
Jensen Jessica D. |
EVP Clinical Development |
RSU 부여 |
136,055 |
$6.78 |
$922.45K |
136,055 |
| 2023-03-28 |
Kelly Justyna |
Chief Operating Officer |
RSU 부여 |
98,358 |
$6.78 |
$666.87K |
98,358 |
| 2023-03-21 |
Hogue Gerald L. |
Director |
옵션 행사 (매도) |
17,936 |
$6.97 |
$125.01K |
17,936 |
| 2022-11-29 |
Mccann Joe A. |
Chief Executive Officer |
정보 매수 |
2,160 |
$6.64 |
$14.34K |
3,616,313 |
| 2022-11-28 |
Malik Rajesh |
Director |
정보 매수 |
3,700 |
$6.66 |
$24.64K |
3,700 |
| 2022-11-25 |
Hogue Gerald L. |
Director |
정보 매수 |
3,660 |
$6.82 |
$24.94K |
3,660 |
| 2022-11-23 |
Lubner David Charles |
Director |
정보 매수 |
3,600 |
$6.85 |
$24.66K |
3,600 |
| 2022-11-21 |
Margolin Yael |
Director |
정보 매수 |
1,710 |
$6.56 |
$11.22K |
1,710 |
| 2022-11-18 |
Silber Allan C |
Executive Chairman |
정보 매수 |
22,397 |
$6.50 |
$145.58K |
4,268,605 |
| 2022-11-18 |
Goodman Jonathan R. |
Director |
정보 매수 |
6,000 |
$6.33 |
$37.98K |
41,872 |
| 2022-11-17 |
Silber Allan C |
Executive Chairman |
정보 매수 |
27,603 |
$6.00 |
$165.62K |
4,246,208 |
| 2022-06-02 |
Lubner David Charles |
Director |
RSU 부여 |
25,614 |
$8.31 |
$212.85K |
25,614 |
| 2022-06-02 |
Malik Rajesh |
Director |
RSU 부여 |
25,614 |
- |
- |
25,614 |
| 2022-06-02 |
Goodman Jonathan R. |
Director |
RSU 부여 |
25,614 |
- |
- |
25,614 |
| 2022-06-02 |
Margolin Yael |
Director |
RSU 부여 |
25,614 |
- |
- |
25,614 |
| 2022-06-02 |
Hogue Gerald L. |
Director |
RSU 부여 |
25,614 |
- |
- |
25,614 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료